Latest news
AREDS2 supplements slow sight loss in late-stage dry AMD
Posted: Friday 19 July 2024
New research has found that taking a daily vitamin and mineral supplement can slow the progression of geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD).
Find out more
Radiation treatment could reduce frequency of injections
Posted: Tuesday 2 July 2024
A new study led by researchers from King's College London and King's College Hospital NHS Foundation Trust has shown that radiation could significantly reduce the number of injections needed to treat wet age-related macular degeneration (AMD).
Find out more
"I know my eyesight will change, so I want to live in the here and now"
Posted: Monday 24 June 2024
Nancy assumed her vision changes were just part of getting older. When she noticed blank spots and disappearing words while reading, she thought she needed a new prescription.
Find out more
Stopping the build-up of toxic waste in dry AMD
Posted: Monday 24 June 2024
In dry age-related macular degeneration (AMD), toxic waste builds up in the retina because cells can't clear it. Dr. Arjuna Ratnayaka is researching ways to activate the cells’ waste removal system to reduce this buildup and protect vision.
Find out more
Boosting key protein in eye cells shows promise in preventing AMD
Posted: Friday 7 June 2024
Increasing the levels of a key protein in eye cells may help protect against age-related macular degeneration (AMD), according to new research led by the University of Bristol.
Find out more
Macular disease top priority in UK eye research
Posted: Tuesday 4 June 2024
Macular disease has been identified as a top priority for eye care research in the UK over the next five years, according to a new study published in the journal Eye.
Find out more
New study identifies 87 genes linked to AMD
Posted: Friday 26 April 2024
Researchers at the National Eye Institute in the USA have discovered 87 genes in retinal cells that could be affected by environmental factors which may influence the risk of developing age-related macular degeneration (AMD).
Find out more
Macular Society partners with UK’s largest health research programme
Posted: Friday 5 April 2024
The Macular Society is proud to announce a new partnership with Our Future Health, a groundbreaking initiative aimed at revolutionising research into health conditions such as age-related macular degeneration (AMD).
Find out more
Home monitoring for patients with AMD
Posted: Wednesday 3 April 2024
Health tech startup OKKO Health has shared new insights from its UK research study on home monitoring for age-related macular degeneration (AMD). The study is being carried out in collaboration with the Macular Society.
Find out more
‘Regular injections essential in maintaining vision’
Posted: Wednesday 27 March 2024
Early diagnosis, prompt initial treatment, and regular injections help stabilise vision in most eyes with wet age-related macular degeneration (AMD), according to a new report published by the Royal College of Ophthalmologists
Find out more
All you need to know about implantable magnifying lenses for macular disease
Posted: Monday 25 March 2024
Intraocular lenses (IOLs) were the focus of our My Macular and Me webinar in March, as Dr Julie Silvestri shed light on the potential of these devices, which aim to improve vision for people living with sight loss.
Find out more
Increased dose of Eylea to extend treatment intervals
Posted: Friday 1 March 2024
Renowned retinal specialist Dr Kenneth Fan has called the higher approved dose of Eylea for patients with wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO), “a pivotal moment” for the treatment of these conditions.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter